These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 1281840)

  • 1. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis.
    Crofford LJ; Sano H; Karalis K; Webster EL; Goldmuntz EA; Chrousos GP; Wilder RL
    J Clin Invest; 1992 Dec; 90(6):2555-64. PubMed ID: 1281840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
    Webster EL; Barrientos RM; Contoreggi C; Isaac MG; Ligier S; Gabry KE; Chrousos GP; McCarthy EF; Rice KC; Gold PW; Sternberg EM
    J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis.
    Crofford LJ; Sano H; Karalis K; Friedman TC; Epps HR; Remmers EF; Mathern P; Chrousos GP; Wilder RL
    J Immunol; 1993 Aug; 151(3):1587-96. PubMed ID: 8335947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin releasing hormone and the hypothalamic-pituitary-adrenal axis in the regulation of inflammatory arthritis.
    Wilder RL
    Agents Actions Suppl; 1993; 41():3-9. PubMed ID: 8317340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats.
    Sternberg EM; Young WS; Bernardini R; Calogero AE; Chrousos GP; Gold PW; Wilder RL
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4771-5. PubMed ID: 2786636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats.
    Sternberg EM; Glowa JR; Smith MA; Calogero AE; Listwak SJ; Aksentijevich S; Chrousos GP; Wilder RL; Gold PW
    Brain Res; 1992 Jan; 570(1-2):54-60. PubMed ID: 1319794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular transplantation of embryonic neuronal tissue from inflammatory resistant into inflammatory susceptible rats suppresses specific components of inflammation.
    Misiewicz B; Poltorak M; Raybourne RB; Gomez M; Listwak S; Sternberg EM
    Exp Neurol; 1997 Aug; 146(2):305-14. PubMed ID: 9270039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats.
    Patchev VK; Kalogeras KT; Zelazowski P; Wilder RL; Chrousos GP
    Endocrinology; 1992 Sep; 131(3):1453-7. PubMed ID: 1505475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritis.
    Murphy EP; McEvoy A; Conneely OM; Bresnihan B; FitzGerald O
    Arthritis Rheum; 2001 Apr; 44(4):782-93. PubMed ID: 11315917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro regulation of pituitary ACTH secretion in inflammatory disease susceptible Lewis (LEW/N) and inflammatory disease resistant Fischer (F344/N) rats.
    Zelazowski P; Smith MA; Gold PW; Chrousos GP; Wilder RL; Sternberg EM
    Neuroendocrinology; 1992 Oct; 56(4):474-82. PubMed ID: 1335552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1 alpha corticotropin-releasing hormone receptor.
    McEvoy AN; Bresnihan B; FitzGerald O; Murphy EP
    Arthritis Rheum; 2001 Aug; 44(8):1761-7. PubMed ID: 11508426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone.
    Calogero AE; Sternberg EM; Bagdy G; Smith C; Bernardini R; Aksentijevich S; Wilder RL; Gold PW; Chrousos GP
    Neuroendocrinology; 1992 May; 55(5):600-8. PubMed ID: 1350069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease.
    Patchev VK; Mastorakos G; Brady LS; Redwine J; Wilder RL; Chrousos GP
    Neuroendocrinology; 1993 Jul; 58(1):106-10. PubMed ID: 8264843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.
    Sano H; Hla T; Maier JA; Crofford LJ; Case JP; Maciag T; Wilder RL
    J Clin Invest; 1992 Jan; 89(1):97-108. PubMed ID: 1729286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats.
    Sternberg EM; Hill JM; Chrousos GP; Kamilaris T; Listwak SJ; Gold PW; Wilder RL
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2374-8. PubMed ID: 2538840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arthritis-susceptible Lewis rats fail to emerge from the stress hyporesponsive period.
    Aksentijevich S; Whitfield HJ; Young WS; Wilder RL; Chrousos GP; Gold PW; Sternberg EM
    Brain Res Dev Brain Res; 1992 Jan; 65(1):115-8. PubMed ID: 1551226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hypothalamic [3H]flunitrazepam binding in hypothalamic-pituitary-adrenal axis hyporesponsive Lewis rats.
    Smith CC; Hauser E; Renaud NK; Leff A; Aksentijevich S; Chrousos GP; Wilder RL; Gold PW; Sternberg EM
    Brain Res; 1992 Jan; 569(2):295-9. PubMed ID: 1311618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1 beta and alpha MSH: studies in rats with different susceptibility to inflammatory disease.
    Zelazowski P; Patchev VK; Zelazowska EB; Chrousos GP; Gold PW; Sternberg EM
    Brain Res; 1993 Dec; 631(1):22-6. PubMed ID: 8298992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats.
    Karalis K; Crofford L; Wilder RL; Chrousos GP
    Endocrinology; 1995 Jul; 136(7):3107-12. PubMed ID: 7789338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.